Robert Rifkin, MD from Rocky Mountain Cancer Center discusses FDA approval of several CAR-T Cell therapies and hope to make new therapies accessible to patients at the 2017 American Society of Hematology.
FDA Approval of Several CAR-T Cell Therapies – Hope to make new therapies accessible to patients
